DK0656360T3 - Trifluormethylpyrroloindolcarboxylesterderivater samt fremgangsmåde til fremstilling deraf - Google Patents

Trifluormethylpyrroloindolcarboxylesterderivater samt fremgangsmåde til fremstilling deraf

Info

Publication number
DK0656360T3
DK0656360T3 DK94908108T DK94908108T DK0656360T3 DK 0656360 T3 DK0656360 T3 DK 0656360T3 DK 94908108 T DK94908108 T DK 94908108T DK 94908108 T DK94908108 T DK 94908108T DK 0656360 T3 DK0656360 T3 DK 0656360T3
Authority
DK
Denmark
Prior art keywords
trifluoromethylpyrroloindole
ester derivatives
preparation
carboxyl ester
arylsulfonyloxy
Prior art date
Application number
DK94908108T
Other languages
English (en)
Inventor
Shiro Terashima
Yasumichi Fukuda
Yasuo Oomori
Original Assignee
Sagami Chem Res
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sagami Chem Res, Kyorin Seiyaku Kk filed Critical Sagami Chem Res
Application granted granted Critical
Publication of DK0656360T3 publication Critical patent/DK0656360T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Laminated Bodies (AREA)
DK94908108T 1992-08-21 1993-08-19 Trifluormethylpyrroloindolcarboxylesterderivater samt fremgangsmåde til fremstilling deraf DK0656360T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP22286292 1992-08-21
JP20425593A JP3514490B2 (ja) 1992-08-21 1993-08-18 トリフルオロメチルピロロインドールカルボン酸エステル誘導体及びその製造方法
PCT/JP1993/001159 WO1994004535A1 (en) 1992-08-21 1993-08-19 Trifluoromethylpyrroloindole carboxylic ester derivative and process for producing the same

Publications (1)

Publication Number Publication Date
DK0656360T3 true DK0656360T3 (da) 2003-03-17

Family

ID=26514369

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94908108T DK0656360T3 (da) 1992-08-21 1993-08-19 Trifluormethylpyrroloindolcarboxylesterderivater samt fremgangsmåde til fremstilling deraf

Country Status (13)

Country Link
US (1) US5629430A (da)
EP (1) EP0656360B1 (da)
JP (1) JP3514490B2 (da)
KR (2) KR100312444B1 (da)
AT (1) ATE228132T1 (da)
CA (1) CA2142869C (da)
DE (1) DE69332504T2 (da)
DK (1) DK0656360T3 (da)
ES (1) ES2188608T3 (da)
HU (1) HU221041B1 (da)
PT (1) PT656360E (da)
TW (1) TW394774B (da)
WO (1) WO1994004535A1 (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996016965A1 (fr) * 1994-11-29 1996-06-06 Kyorin Pharmaceutical Co., Ltd. Derives d'acrylamide et leur procede de production
AU3463197A (en) * 1996-07-23 1998-02-10 Kyowa Hakko Kogyo Co. Ltd. Dc-89 derivatives
CA2278682C (en) * 1997-01-24 2005-10-04 Kyorin Pharmaceutical Co., Ltd. Pyrroloindole derivatives and intermediates in producing the same
JP2001525382A (ja) * 1997-12-08 2001-12-11 ザ スクリップス リサーチ インスティテュート Ｃｃ−１０６５／デュオカルマイシン類似体の合成
IL154183A0 (en) 2001-05-31 2003-07-31 Medarex Inc Cytotoxins, prodrugs, linkers and stabilizers useful therefor
US20050215614A1 (en) * 2002-10-15 2005-09-29 Rigel Pharmaceuticals, Inc. Substituted indoles and their use as hcv inhibitors
GB0403038D0 (en) 2004-02-11 2004-03-17 Novartis Ag Organic compounds
US7517903B2 (en) * 2004-05-19 2009-04-14 Medarex, Inc. Cytotoxic compounds and conjugates
US7691962B2 (en) * 2004-05-19 2010-04-06 Medarex, Inc. Chemical linkers and conjugates thereof
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
WO2006089230A2 (en) * 2005-02-18 2006-08-24 Medarex, Inc. Human monoclonal antibodies to prostate specific membrane antigen (psma)
US7714016B2 (en) * 2005-04-08 2010-05-11 Medarex, Inc. Cytotoxic compounds and conjugates with cleavable substrates
AU2006294554B2 (en) * 2005-09-26 2013-03-21 E. R. Squibb & Sons, L.L.C. Antibody-drug conjugates and methods of use
WO2007051081A1 (en) 2005-10-26 2007-05-03 Medarex, Inc. Methods and compounds for preparing cc-1065 analogs
WO2007059404A2 (en) 2005-11-10 2007-05-24 Medarex, Inc. Duocarmycin derivatives as novel cytotoxic compounds and conjugates
TWI412367B (zh) 2006-12-28 2013-10-21 Medarex Llc 化學鏈接劑與可裂解基質以及其之綴合物
JP2010519310A (ja) 2007-02-21 2010-06-03 メダレックス インコーポレイテッド 単一のアミノ酸を有する化学リンカーおよびその複合体
US9901567B2 (en) 2007-08-01 2018-02-27 Syntarga B.V. Substituted CC-1065 analogs and their conjugates
JP5696266B2 (ja) 2007-11-20 2015-04-08 ランケナー インスティテュート フォー メディカル リサーチ ジスルフィド化学療法剤およびその使用方法
PT2344478T (pt) * 2008-11-03 2017-11-28 Syntarga Bv Análogos de cc-1065 e seus conjugados
EP2430178B1 (en) 2009-05-15 2014-07-09 Lankenau Institute for Medical Research Methods and kits for measuring toxicity and oxidative stress in live cells
CA2796712C (en) 2010-04-21 2017-02-28 Syntarga B.V. Novel conjugates of cc-1065 analogs and bifunctional linkers
EP2922818B1 (en) 2012-11-24 2018-09-05 Hangzhou Dac Biotech Co., Ltd Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
MX368396B (es) 2014-01-10 2019-10-01 Synthon Biopharmaceuticals Bv Conjugados de anticuerpo-farmaco (adc) de duocarmicina que muestran actividad antitumoral in vivo mejorada.
PL3092010T3 (pl) 2014-01-10 2019-01-31 Synthon Biopharmaceuticals B.V. Sposób oczyszczania połączonych cysteiną koniugatów przeciwciało-lek
JP6224268B2 (ja) 2014-01-10 2017-11-01 シントン・バイオファーマシューティカルズ・ビー．ブイ．Ｓｙｎｔｈｏｎ Ｂｉｏｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｂ．Ｖ． 子宮内膜癌の治療において使用するためのデュオカルマイシンａｄｃ
ES2960619T3 (es) 2014-02-28 2024-03-05 Hangzhou Dac Biotech Co Ltd Enlazadores cargados y sus usos para la conjugación
AU2015242213A1 (en) 2015-07-12 2018-03-08 Hangzhou Dac Biotech Co., Ltd Bridge linkers for conjugation of cell-binding molecules
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
CN110099682B (zh) 2016-11-14 2023-03-31 杭州多禧生物科技有限公司 偶联连接体，含有此连接体的细胞结合分子-药物偶联物及其制备和应用
CN112724068A (zh) * 2020-12-30 2021-04-30 蔡桂坡 具有hdac抑制活性的吲哚类衍生物的合成方法及肿瘤应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978757A (en) * 1984-02-21 1990-12-18 The Upjohn Company 1,2,8,8a-tetrahydrocyclopropa (C) pyrrolo [3,2-e)]-indol-4(5H)-ones and related compounds
JP2598116B2 (ja) * 1988-12-28 1997-04-09 協和醗酵工業株式会社 新規物質ｄｃ１１３
JP2510335B2 (ja) * 1989-07-03 1996-06-26 協和醗酵工業株式会社 Ｄｃ―８８ａ誘導体
JP3037965B2 (ja) * 1990-06-20 2000-05-08 財団法人相模中央化学研究所 ２―アルコキシカルボニル―２―メチル―１―オキソ―１，２，３，６，７，８―ヘキサヒドロ―ベンゾ〔１，２―ｂ；４，３―ｂ´〕ジピロール誘導体
JPH0499774A (ja) * 1990-08-14 1992-03-31 Sagami Chem Res Center ２―エピデュオカルマイシンａおよびその製造中間体

Also Published As

Publication number Publication date
ES2188608T3 (es) 2003-07-01
CA2142869A1 (en) 1994-03-03
DE69332504D1 (de) 2003-01-02
US5629430A (en) 1997-05-13
KR100312445B1 (ko) 2001-11-09
AU689443B2 (en) 1998-04-02
KR100312444B1 (ko) 2002-02-28
PT656360E (pt) 2003-02-28
ATE228132T1 (de) 2002-12-15
AU4761893A (en) 1994-03-15
JP3514490B2 (ja) 2004-03-31
CA2142869C (en) 2002-01-01
EP0656360A1 (en) 1995-06-07
HUT71493A (en) 1995-11-28
EP0656360A4 (en) 1995-08-30
WO1994004535A1 (en) 1994-03-03
HU221041B1 (hu) 2002-07-29
JPH06116269A (ja) 1994-04-26
EP0656360B1 (en) 2002-11-20
HU9500494D0 (en) 1995-04-28
TW394774B (en) 2000-06-21
DE69332504T2 (de) 2003-10-02

Similar Documents

Publication Publication Date Title
DK0656360T3 (da) Trifluormethylpyrroloindolcarboxylesterderivater samt fremgangsmåde til fremstilling deraf
DK0609960T3 (da) Nye N-heteroarylamidderivater som inhibitorer af acylcoenzym-A: cholesterolacyltransferase
DE69420068T2 (de) 1H-Indol-3-Acetamid-Derivate als sPLA2-Inhibitoren
ATE132150T1 (de) 3-alkenyl-1-azabicyclo(3.2.0)hept-2-en-2- carbonsäure-verbindungen
KR860004049A (ko) 퀴놀론카복실산 유도체의 제조방법
NO20014119L (no) Medikament inneholdende et sulfopyranosylacylglycerolderivat
ATE168113T1 (de) Antiallergische, entzündungshemmende und anti-paf pyridazinverbindungen
DE69017174D1 (de) Substituierte Oxophtalazinyl-Essigsäuren und deren Analogen.
DK0571243T3 (da) Thiochromanderivater, fremgangsmåder til fremstilling heraf samt farmaceutiske midler indeholdende d isse
CO4890844A1 (es) Nuevos retinoides
DE69001513T2 (de) Polyprenylverbindung enthaltende Zusammensetzung für weiche Kapseln.
DK0654473T3 (da) Cyclopropanderivater og antivirale midler med indhold deraf
ATE146481T1 (de) Epoxysuccinamidsäurederivat
ES8101646A1 (es) Un procedimiento para producir un compuesto opticamente ac- tivo
DE3265110D1 (en) New compound having antiinflammatory, analgesic and mucoregulating activity, process for its production and relative pharmaceutical compositions
EP0657443A4 (en) OPTICALLY ACTIVE CARBOXAMIDE DERIVATIVES.
ATE120731T1 (de) Optisch aktives derivat der d-2-(6-methoxy-2- naphthyl)-propionsäure und es enthaltende pharmazeutische zusammensetzungen.
NO175255C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive alkylestere av 2-(4-(2-piperidino-etoksy)-benzoyl)-benzosyre med forgrenet kjede
ES2042727T3 (es) Acidos 1,3,4,9-tetrahidropirano(3,4-b)indol-1-acetico.
ITMI931848A1 (it) Glicoconiugati anfifilici sintetici attivi sul sistema nervoso centrale, procedimento per la loro preparazione e relative